跳至主要内容
临床试验/IRCT2015010111335N4
IRCT2015010111335N4已完成未知

The effect of chamomile (Matricaria recutita L.) on serum levels of tumor necrosis factor-a (TNF-a), interlukin-1ß and matrix metalloproteinase-3 (MMP3) in rheumatoid arthritis women patients: a randomized controlled clinical trial

Vice Chancellor for Research, Tabriz University of Medical Sciences0 个研究点目标入组 44 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
44

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 65 years(—)
性别
Female

入选标准

  • 1) Subjects diagnosed with rheumatoid arthritis, based on American College of Rheumatology (ACR-2010) criteria; 2) Patients with moderate and less rheumatoid arthritis score (DAS-28<5.1); 3) Stable medication for at least 3 weeks prior to the intervention and during that; 4) Willing to participate in the study and giving written consent ; 5) Ages between 20 and 65; 6) Have a body mass index (BMI) less than 30 and more than 18.5
  • Exclusion criteria: 1) Pregnant and lactating women; 2) Patients with cardiovascular, lung, hepatic, kidney and blood diseases; 3) Having chronic inflammatory diseases such as Sjogern, Sicca, Multiple sclerosis, Lupus Erythematosus and Hashimoto’s diseases; 4) Patients with gastroduodenal ulcer; 5) Patients with a high sensibility to the experimental drugs; 6) Patients participating in another study just 3 weeks before the intervention; 7) Taking any vitamin, mineral or omega 3 supplement 3 months before the intervention.

排除标准

  • 未提供

研究者

发起方
Vice Chancellor for Research, Tabriz University of Medical Sciences

相似试验